Global Animal Blood Plasma and Derivatives Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Animal Blood Plasma and Derivatives market size was valued at USD 1027.2 million in 2023 and is forecast to a readjusted size of USD 1379.9 million by 2030 with a CAGR of 4.3% during review period.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 220%.
The Global Info Research report includes an overview of the development of the Animal Blood Plasma and Derivatives industry chain, the market status of Food & Beverages (Immunoglobulin, Fibrinogen), Pharmaceuticals (Immunoglobulin, Fibrinogen), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Animal Blood Plasma and Derivatives.
Regionally, the report analyzes the Animal Blood Plasma and Derivatives markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Animal Blood Plasma and Derivatives market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Animal Blood Plasma and Derivatives market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Animal Blood Plasma and Derivatives industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immunoglobulin, Fibrinogen).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Animal Blood Plasma and Derivatives market.
Regional Analysis: The report involves examining the Animal Blood Plasma and Derivatives market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Animal Blood Plasma and Derivatives market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Animal Blood Plasma and Derivatives:
Company Analysis: Report covers individual Animal Blood Plasma and Derivatives players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Animal Blood Plasma and Derivatives This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Food & Beverages, Pharmaceuticals).
Technology Analysis: Report covers specific technologies relevant to Animal Blood Plasma and Derivatives. It assesses the current state, advancements, and potential future developments in Animal Blood Plasma and Derivatives areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Animal Blood Plasma and Derivatives market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Animal Blood Plasma and Derivatives market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum
Thrombin
New Born Calf Serum
Market segment by Application
Food & Beverages
Pharmaceuticals
Cosmetics
Feed
Others
Market segment by players, this report covers
Proliant Inc.
Thermo Fisher Scientific, Inc.
Merck KGaA
Kraeber & Co GmbH
LAMPIRE Biological Laboratories, Inc.
Lake Immunogenics, Inc.
Rocky Mountain Biologicals Inc.
ANZCO Foods Ltd.
Auckland BioSciences Ltd.
Bovogen Biologicals Pty Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Animal Blood Plasma and Derivatives product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Animal Blood Plasma and Derivatives, with revenue, gross margin and global market share of Animal Blood Plasma and Derivatives from 2019 to 2024.
Chapter 3, the Animal Blood Plasma and Derivatives competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Animal Blood Plasma and Derivatives market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Animal Blood Plasma and Derivatives.
Chapter 13, to describe Animal Blood Plasma and Derivatives research findings and conclusion.